SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 73 filers reported holding SUNESIS PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $941,000 | -56.7% | 384,000 | -54.9% | 0.00% | -50.0% |
| Q4 2014 | $2,173,000 | -44.9% | 852,100 | +54.3% | 0.00% | -50.0% |
| Q3 2014 | $3,942,000 | -33.2% | 552,100 | -39.0% | 0.00% | -33.3% |
| Q2 2014 | $5,901,000 | +12.1% | 905,100 | +13.7% | 0.01% | 0.0% |
| Q1 2014 | $5,263,000 | +83.8% | 796,200 | +31.8% | 0.01% | +100.0% |
| Q4 2013 | $2,864,000 | -4.4% | 604,300 | 0.0% | 0.00% | -25.0% |
| Q3 2013 | $2,997,000 | -4.8% | 604,300 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $3,148,000 | – | 604,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,869,261 | $32,186,000 | 2.31% |
| GREAT POINT PARTNERS LLC | 193,567 | $1,279,000 | 0.67% |
| Visium Asset Management, LP | 4,526,750 | $29,922,000 | 0.48% |
| Healthcare Value Capital, LLC | 103,185 | $682,000 | 0.45% |
| ALYDAR PARTNERS LLC | 550,565 | $3,639,000 | 0.36% |
| Rhenman & Partners Asset Management AB | 147,403 | $974,000 | 0.29% |
| HealthCor Management, L.P. | 690,000 | $4,561,000 | 0.27% |
| Sivik Global Healthcare LLC | 63,087 | $417,000 | 0.26% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,379,278 | $9,117,000 | 0.22% |
| Healthcare Value Capital, LLC | 50,000 | $331,000 | 0.22% |